New Anti-Static Stat-Loy Compounds

Patients and medical device OEMs can now breathe easier thanks to SABIC Innovative Plastics’ new breakthrough anti-static compounds for inhalation devices. During this year's MD&M West SABIC officials launched three major additions to its family of high-performance LNP Stat-Loy specialty compounds. The new transparent materials provide permanent anti-static properties, eliminating the need for expensive secondary operations, and help ensure repeatability of dosing and potentially lower drug costs through more-efficient aerosol and powder dispensing. The new LNP Stat-Loy specialty compound grades are also pre-assessed for biocompatibility according to ISO 10993 to help manufacturers expedite compliance and time to market. SABIC Innovative Plastics’ ongoing investment in these and other leading-edge healthcare technologies illustrate the company’s commitment to its customers by actively addressing mounting medical industry demand for improved patient safety and lower manufacturing costs.

“SABIC Innovative Plastics is clearly delivering a fast-expanding portfolio of high-end, highly specialized materials to the medical device industry,” says David DeVito, LNP compounds product marketing manager, SABIC Innovative Plastics. “Our new transparent, anti-static LNP Stat-Loy compounds will help drive exceptional design flexibility to create very efficient inhalation devices that can optimize patient dosages for improved safety, while simultaneously slashing manufacturing system costs.”

Inherent Anti-static Performance Assists With Consistent, Full Dosing
Static electricity is a major challenge in the effective use of inhalation devices; tiny drug particles can build up an electrostatic charge causing them to adhere to the device instead of being dispensed to the patient. SABIC Innovative Plastics’ LNP Stat-Loy compounds provide built-in, permanent anti-static performance to assist with the efficient delivery of a full dose of a powder or aerosol to the patient each time, contributing to improved safety and better outcomes. Unlike older inhalers that utilized coatings to control static charges, the inherent anti-static properties of LNP Stat-Loy compounds avoid the need for costly secondary operations.

The new LNP Stat-Loy compounds are available in three transparent resin systems: acrylonitrile butadiene styrene (ABS); polymethylmethacrylate (PMMA)/acrylic; and Xylex resin, a polycarbonate (PC)/polyester alloy. The superior clarity of these compounds ensures excellent visibility of device contents while providing attractive aesthetics. The materials can be easily colored for appearance and drug identification. Other important features of the new compounds include excellent impact strength and cleanability.

LNP Stat-Loy compounds are available in opaque resins such as polyamide 6, polybutylene terephthalate (PBT), polyoxymethylene (POM), and polypropylene (PP), enabling manufacturers to combine opaque and clear components for design or functional purposes.